Anebulo Pharmaceuticals Inc

For the period ended Jun 30, 2024. Filed Sep 25, 2024.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Sep 25, 2024

ANEB$0.34-1.8%Stored close · as of Jul 8, 2026

Opening this filing…